Breaking News Instant updates and real-time market news.

2020-04-22 14:00:35 BAYRY Bayer $0.00 / + (+0.00%) 14:00 04/22/20 04/22 14:00 04/22/20 14:00	Bayer price target lowered to EUR 83 from EUR 86 at Morgan Stanley Morgan Stanley analyst Mark Purcell lowered the firm's price target on Bayer to EUR 83 from EUR 86 and keeps an Overweight rating on the shares.	23 Apr 27 Apr
BAYRY Bayer $0.00 / + (+0.00%) 03/13/20 Goldman Sachs Bayer price target lowered to EUR 76 from EUR 77 at Goldman Sachs 03/11/20 Deutsche Bank Deutsche Bank names Bayer as 'Catalyst Call' buy idea 03/04/20 Deutsche Bank Bayer upgraded to Buy from Hold at Deutsche Bank 12/19/19 BofA Elanco upgraded to Buy from Neutral at BofA/Merrill

2020-04-22 14:00:35

BAYRY

Bayer

$0.00 / + (+0.00%)

14:00

04/22/20

04/22

14:00

04/22/20

14:00

Bayer price target lowered to EUR 83 from EUR 86 at Morgan Stanley

Morgan Stanley analyst Mark Purcell lowered the firm's price target on Bayer to EUR 83 from EUR 86 and keeps an Overweight rating on the shares.

23
Apr
27
Apr

BAYRY Bayer

$0.00 / + (+0.00%)

03/13/20 Goldman Sachs: Bayer price target lowered to EUR 76 from EUR 77 at Goldman Sachs

03/11/20 Deutsche Bank: Deutsche Bank names Bayer as 'Catalyst Call' buy idea

03/04/20 Deutsche Bank: Bayer upgraded to Buy from Hold at Deutsche Bank

12/19/19 BofA: Elanco upgraded to Buy from Neutral at BofA/Merrill

TODAY'S FREE FLY STORIES

Upgrade	Latam Airlines upgraded to Hold from Sell at Deutsche Bank » 05:23 03/05/21 03/05 05:23 03/05/21 05:23 LTM Latam Airlines $3.18 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LTM Latam Airlines $3.18 / + (+0.00%) 11/09/20 Seaport Global Azul upgraded to Buy from Neutral at Seaport Global 05/28/20 BofA Latam Airlines reinstated with an Underperform at BofA 05/27/20 Deutsche Bank Latam Airlines downgraded to Sell from Hold at Deutsche Bank 05/26/20 Raymond James Latam Airlines downgraded to Underperform from Outperform at Raymond James
Upgrade	Exxon Mobil upgraded to Hold from Sell at DZ Bank » 05:22 03/05/21 03/05 05:22 03/05/21 05:22 XOM Exxon Mobil $58.74 / +2.22 (+3.93%) DZ Bank analyst Werner… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/03/21 Exxon Mobil must change direction, not just appoint board candidates, CURE says 03/03/21 Exxon Mobil sees FY21 capital spending $16B-$19B 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/04/21 MKM Partners Exxon Mobil price target raised to $60 from $56 at MKM Partners 03/04/21 Morgan Stanley Exxon Mobil price target raised to $60 from $57 at Morgan Stanley 03/04/21 Truist Exxon Mobil price target raised to $60 from $50 at Truist 03/04/21 Citi Exxon Mobil price target raised to $53 from $44 at Citi XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/04/21 Exxon sues Macquarie to avoid paying $11.7M for missed deliveries, Reuters says 03/04/21 OPEC+ agrees to maintain oil output levels, Bloomberg reports 03/02/21 Exxon CEO says economics, policies creating carbon capture market, Reuters says 03/01/21 Ubben, Angelakis to join board of Exxon Mobil, CNBC reports XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Wall Street's top stories for Tuesday XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/03/21 Exxon Mobil call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish
Hot Stocks	Dada Nexus, Unilever announce livestreaming e-commerce event partnership » 05:22 03/05/21 03/05 05:22 03/05/21 05:22 DADA Dada Nexus $32.13 / -2.77 (-7.94%) , UL Unilever $53.52 / +0.11 (+0.21%) Dada Group (DADA) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options DADA UL DADA Dada Nexus $32.13 / -2.77 (-7.94%) 01/29/21 Dada appoints Rui Yu to board of directors 01/27/21 Dada Group, Ferrero enter pact to create on-demand retail model for snacks 01/25/21 Dada Nexus works with retailers to provide delivery service in Shijiazhuang 01/15/21 Dada Nexus announces JD Daojia partners with over 20 regional supermarkets UL Unilever $53.52 / +0.11 (+0.21%) 12/21/20 Dada Nexus, Unilever announce new strategic partnership 12/18/20 Unilever to end advertising pause on Facebook, Twitter in U.S. in January 11/30/20 Unilever completes unification of group legal structure 11/25/20 Unilever to acquire SmartyPants Vitamins, terms not disclosed DADA UL DADA Dada Nexus $32.13 / -2.77 (-7.94%) 01/18/21 CICC Dada Nexus initiated with an Outperform at CICC 01/07/21 KeyBanc Dada Nexus initiated with an Overweight at KeyBanc 12/08/20 Fly Intel: Top five analyst downgrades 12/08/20 Morgan Stanley Dada Nexus downgraded to Equal Weight on competition risk at Morgan Stanley UL Unilever $53.52 / +0.11 (+0.21%) 02/08/21 Barclays Unilever price target lowered to EUR 48 from EUR 55 at Barclays 12/08/20 Investec Unilever upgraded to Buy from Hold at Investec 12/03/20 Societe Generale Unilever initiated with a Buy at Societe Generale 11/25/20 Jefferies Jefferies sees 'strong buying opportunity' upcoming after Unilever unification DADA DADA Dada Nexus $32.13 / -2.77 (-7.94%) 11/19/20 Dada Nexus sees Q4 revenue RMB2B-RMB2.1B 11/19/20 Dada Nexus reports Q3 adjusted EPS RMB0.36 vs RMB1.71 last year 03 Dec 05 Jun UL UL Unilever $53.52 / +0.11 (+0.21%) 01/20/21 Unilever says its suppliers must pay staff 'living wage,' BBC says 01/13/21 Unilever CEO encourages employees to get COVID vaccine, Reuters says 11/30/20 Unilever testing out four-day work week in New Zealand, Reuters says 11/17/20 Unilever targets EUR1B in sales from plant-based products by 2027, FT reports DADA DADA Dada Nexus $32.13 / -2.77 (-7.94%) 11/30/20 Fly Intel: After-Hours Movers 03/08/21 Dada Nexus - DADA DADA DADA Dada Nexus $32.13 / -2.77 (-7.94%) 12/23/20 new option listings and one option delisting on December 23rd
Downgrade	Wipro downgraded to Sell from Reduce at ICICI Securities » 05:22 03/05/21 03/05 05:22 03/05/21 05:22 WIT Wipro $6.44 / -0.02 (-0.31%) ICICI Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings WIT Wipro $6.44 / -0.02 (-0.31%) 03/04/21 Wipro to acquire Capco 02/15/21 Wipro announces five-year strategic partnership with Telefonica Germany 01/15/21 Wipro chosen by Fiat Chrysler to establish first global digital hub in India 01/13/21 Wipro sees Q4 IT Services revenue up 1.5%-3.5% sequentially to $2.1B-$2.14B WIT Wipro $6.44 / -0.02 (-0.31%) 12/21/20 Goldman Sachs Wipro resumed with a Sell at Goldman Sachs 10/14/20 Investec Wipro downgraded to Hold from Buy at Investec 10/06/20 ICICI Securities Wipro downgraded to Hold from Buy at ICICI Securities 07/16/20 Wedbush Infosys upgraded to Outperform on improving visibility at Wedbush WIT Wipro $6.44 / -0.02 (-0.31%) 01/13/21 Wipro reports Q3 EPS 7c, two estimates 6c 10/13/20 Wipro sees Q3 IT Services revenue up 1.5%-3.5% sequentially to $2.02B-$2.06B 10/13/20 Wipro reports Q2 EPS 6c, two estimates 6c
Upgrade	Energias de Portugal upgraded to Buy from Hold at Societe Generale » 05:21 03/05/21 03/05 05:21 03/05/21 05:21 EDPFY Energias de Portugal $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research EDPFY Energias de Portugal $0.00 / + (+0.00%) 01/20/21 Morgan Stanley Energias de Portugal resumed with an Overweight at Morgan Stanley 09/21/20 RBC Capital Energias de Portugal upgraded to Sector Perform at RBC Capital 09/16/20 Credit Suisse Energias de Portugal price target raised to EUR 5 at Credit Suisse 08/28/20 JPMorgan Energias de Portugal price target raised to EUR 4.65 from EUR 4.50 at JPMorgan

Downgrade	Roche downgraded to Hold from Buy at Erste Group » 05:20 03/05/21 03/05 05:20 03/05/21 05:20 RHHBY Roche $0.00 / + (+0.00%) Erste Group analyst Hans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RHHBY Roche $0.00 / + (+0.00%) 03/04/21 Genentech's Acterma approved by FDA for regulating pulmonary function in SSc-ILD 03/04/21 Dicerna, Roche begin combo trial of GalXC for chronic HBV treatment 03/03/21 Adaptive says Genentech suspends development of shared antigen target candidate 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail RHHBY Roche $0.00 / + (+0.00%) 03/03/21 Goldman Sachs Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks 03/25/21 Roche - RHHBY
Upgrade	Amadeus IT Group upgraded to Buy from Hold at Erste Group » 05:20 03/05/21 03/05 05:20 03/05/21 05:20 AMADY Amadeus IT Group $0.00 / + (+0.00%) Erste Group analyst Hans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research AMADY Amadeus IT Group $0.00 / + (+0.00%) 02/26/21 Microsoft, Amadeus IT Group announce strategic partnership AMADY Amadeus IT Group $0.00 / + (+0.00%) 03/02/21 UBS Amadeus IT Group price target lowered to EUR 61 from EUR 65 at UBS 03/01/21 JPMorgan Amadeus IT Group price target raised to EUR 58 from EUR 50 at JPMorgan 03/01/21 Oddo BHF Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF 03/01/21 Oddo BHF Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF
Initiation	Cadeler initiated with a Buy at Kepler Cheuvreux » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 CADLF Cadeler $0.00 / + (+0.00%) Kepler Cheuvreux… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CADLF Cadeler $0.00 / + (+0.00%) 01/06/21 DNB Markets Cadeler initiated with a Buy at DNB Markets
Earnings	GSX Techedu reports Q4 EPS (39c), consensus (38c) » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 GSX GSX Techedu $84.11 / -2.9 (-3.33%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSX GSX Techedu $84.11 / -2.9 (-3.33%) 03/03/21 GSX Techedu falls -13.3% 01/13/21 GSX Techedu rises 27.1% 12/07/20 GSX Techedu rises 15.3% 11/23/20 GSX 'as close as possible' to being proven fraud before delisting, Block says GSX GSX Techedu $84.11 / -2.9 (-3.33%) 02/01/21 JPMorgan GSX Techedu downgraded to Underweight from Neutral at JPMorgan 01/29/21 GSX Techedu downgraded to Sell from Neutral at China Merchants 01/28/21 Goldman Sachs GSX Techedu downgraded to Sell from Neutral at Goldman Sachs 12/17/20 Fly Intel: Top five analyst downgrades GSX GSX Techedu $84.11 / -2.9 (-3.33%) 11/20/20 GSX Techedu reports Q3 EPS (57c), consensus (31c) GSX GSX Techedu $84.11 / -2.9 (-3.33%) 12/18/20 Seven whistleblowers have described 'fraud' at GSX Techedu, Aurelius Value says 10/12/20 WSJ article on GSX 'somewhat misses the point,' Muddy Waters says 10/12/20 GSX proves to be one of the year's worst short bets, WSJ says GSX GSX Techedu $84.11 / -2.9 (-3.33%) 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: Wall Street's top stories for Thursday 01/28/21 Fly Intel: Wall Street's top stories at midday 11/20/20 Fly Intel: Wall Street's top stories for Friday 08:00 Today GSX Techedu - GSX GSX GSX Techedu $84.11 / -2.9 (-3.33%) 03/04/21 GSX Techedu put volume heavy and directionally bearish 03/03/21 GSX Techedu put volume heavy and directionally bearish 01/21/21 GSX Techedu call volume above normal and directionally bullish 12/28/20 GSX Techedu put volume heavy and directionally bearish
Upgrade	AXA upgraded to Conviction Buy from Buy at Bryan Garnier » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 AXAHY AXA $0.00 / + (+0.00%) Bryan Garnier analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals AXAHY AXA $0.00 / + (+0.00%) 03/03/21 Deutsche Bank AXA price target raised to EUR 25 from EUR 24.50 at Deutsche Bank 03/02/21 Morgan Stanley AXA price target lowered to EUR 24 from EUR 24.20 at Morgan Stanley 03/01/21 Berenberg AXA price target raised to EUR 23.30 from EUR 21.50 at Berenberg 02/26/21 RBC Capital AXA price target raised to EUR 24 from EUR 23 at RBC Capital AXAHY AXA $0.00 / + (+0.00%) 02/24/21 Baker Hughes, AXA, 16 others wind down work on Nord Stream 2, Reuters says 09/24/20 Allianz and Athora in talks for joint bid for Aviva's French unit, Reuters says

Upgrade	Meggitt upgraded to Outperform from Neutral at Exane BNP Paribas » 05:18 03/05/21 03/05 05:18 03/05/21 05:18 MEGGF Meggitt $0.00 / + (+0.00%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MEGGF Meggitt $0.00 / + (+0.00%) 02/11/21 Morgan Stanley Meggitt price target lowered to 455 GBp from 465 GBp at Morgan Stanley 02/04/21 Jefferies Meggitt price target raised to 500 GBp from 375 GBp at Jefferies 01/08/21 JPMorgan Meggitt price target lowered to 390 GBp from 395 GBp at JPMorgan 12/15/20 Panmure Gordon Meggitt downgraded to Sell from Hold at Panmure Gordon
Upgrade	Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan » 05:17 03/05/21 03/05 05:17 03/05/21 05:17 WOPEY Woodside Petroleum $0.00 / + (+0.00%) JPMorgan analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WOPEY Woodside Petroleum $0.00 / + (+0.00%) 12/09/20 JPMorgan Woodside Petroleum downgraded to Neutral from Overweight at JPMorgan 07/17/20 Citi Woodside Petroleum downgraded to Neutral from Buy at Citi 06/25/20 JPMorgan Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan 05/05/20 Bernstein Woodside Petroleum upgraded to Outperform from Market Perform at Bernstein
Downgrade	Brembo downgraded to Reduce from Hold at Kepler Cheuvreux » 05:16 03/05/21 03/05 05:16 03/05/21 05:16 BRBOF Brembo $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BRBOF Brembo $0.00 / + (+0.00%) 02/01/21 Exane BNP Paribas Brembo downgraded to Underperform from Neutral at Exane BNP Paribas
Upgrade	Belimo Holding upgraded to Hold from Reduce at Kepler Cheuvreux » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 BLHWF Belimo Holding $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BLHWF Belimo Holding $0.00 / + (+0.00%) 12/11/20 Berenberg Belimo Holding price target raised to CHF 8,250 from CHF 8,000 at Berenberg 05/26/20 UBS Belimo Holding price target lowered to CHF 5,150 from CHF 5,200 at UBS 03/18/20 Berenberg Belimo Holding upgraded to Buy from Hold at Berenberg
Earnings	ObsEva reports Q4 EPS (32c), consensus (42c) » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 OBSV ObsEva $3.37 / -0.32 (-8.67%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options OBSV ObsEva $3.37 / -0.32 (-8.67%) 01/11/21 ObsEva provides updates on Yselty program 01/04/21 ObsEva appoints David Renas as CFO 12/10/20 ObsEva announces Yselty met primary endpoint in PRIMROSE 1, PRIMROSE 2 studies 11/24/20 ObsEva submits MAA to EMA for Yselty OBSV ObsEva $3.37 / -0.32 (-8.67%) 01/04/21 H.C. Wainwright ObsEva price target lowered to $17 from $23 at H.C. Wainwright 11/09/20 JPMorgan ObsEva downgraded to Underweight from Neutral at JPMorgan 10/05/20 H.C. Wainwright ObsEva price target lowered to $23 from $36 at H.C. Wainwright 07/07/20 Wedbush Selloff in ObsEva shares 'overdone,' says Wedbush OBSV ObsEva $3.37 / -0.32 (-8.67%) 11/05/20 ObsEva reports Q3 EPS (49c), consensus (34c) 30 Oct OBSV ObsEva $3.37 / -0.32 (-8.67%) 12/10/20 Fly Intel: Pre-market Movers OBSV ObsEva $3.37 / -0.32 (-8.67%) 02/16/21 Largest borrow rate increases among liquid names 01/27/21 Largest borrow rate increases among liquid names 01/22/21 Largest borrow rate increases among liquid names

Initiation	Technip Energies initiated with a Buy at Kepler Cheuvreux » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 THNPF Technip Energies $0.00 / + (+0.00%) Kepler Cheuvreux… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research THNPF Technip Energies $0.00 / + (+0.00%) 03/01/21 Exane BNP Paribas Technip Energies initiated with a Neutral at Exane BNP Paribas 03/01/21 Morgan Stanley Technip Energies initiated with an Overweight at Morgan Stanley 02/22/21 Barclays Technip Energies initiated with an Equal Weight at Barclays
Upgrade	Barclays upgraded to Add from Sell at AlphaValue » 05:14 03/05/21 03/05 05:14 03/05/21 05:14 BCS Barclays $9.21 / -0.235 (-2.49%) AlphaValue upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays committed to medium-term targets, including RoTE of over 10% over time 02/18/21 Barclays sees 'meaningful' y/y RoTe improvement in 2021 02/18/21 Barclays declares 1.0p 2020 full year dividend 01/04/21 Penn National CFO David Williams steps down, Felicia Hendrix to succeed BCS Barclays $9.21 / -0.235 (-2.49%) 02/23/21 JPMorgan Barclays price target raised to 190 GBp from 180 GBp at JPMorgan 02/22/21 RBC Capital Barclays price target raised to 150 GBp from 140 GBp at RBC Capital 02/19/21 Deutsche Bank Barclays price target raised to 200 GBp from 180 GBp at Deutsche Bank 01/28/21 Berenberg Barclays price target raised to 180 GBp from 160 GBp at Berenberg BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays reports Q4 group profit before tax GBP0.6B vs. GBP1.1B last year 10/23/20 Barclays reports Q3 group profit before tax GBP 1.1B vs. GBP 0.2B last year 10/13/20 Fly Intel: What to watch in next round of big banks' earnings reports BCS Barclays $9.21 / -0.235 (-2.49%) 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says 02/18/21 Barclays CEO sees staff returning to office this year, Bloomberg reports 12/16/20 Barclays mulls raising bonus pool for traders by roughly 10%, Bloomberg says 10/01/20 Goldman Sachs to buy GM credit-card business for about $2.5B, WSJ reports BCS Barclays $9.21 / -0.235 (-2.49%) 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/01/20 Fly Intel: Wall Street's top stories for Thursday 09/11/20 The Intersection: Crypto and Wall Street This Week 03/25/21 REITwise 2021 Virtual Conference BCS Barclays $9.21 / -0.235 (-2.49%) 12/16/20 Barclays call volume above normal and directionally bullish 12/14/20 Unusual call flow in option market yesterday 12/11/20 Short-term premium buyer in Barclays 12/11/20 Unusually active option classes on open December 11th
Upgrade	Henkel upgraded to Hold from Sell at Nord/LB » 05:13 03/05/21 03/05 05:13 03/05/21 05:13 HENKY Henkel $0.00 / + (+0.00%) Nord/LB analyst Thorsten… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events HENKY Henkel $0.00 / + (+0.00%) 01/12/21 UBS Henkel price target raised to EUR 81 from EUR 80 at UBS 01/05/21 Barclays Barclays trims Henkel Adhesive estimates on slower recovery expectations 12/03/20 JPMorgan Henkel upgraded to Overweight from Neutral at JPMorgan 11/30/20 Commerzbank Henkel upgraded to Buy from Hold at Commerzbank 03/10/21 Global Consumer & Retail Virtual Conference 2021
Hot Stocks	Moderna announces Takeda NDA submission to distribute COVID-19 vaccine in Japan » 05:12 03/05/21 03/05 05:12 03/05/21 05:12 MRNA Moderna $132.21 / +1.01 (+0.77%) , TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) Moderna (MRNA) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/04/21 Moderna, IBM to collaborate on COVID vaccine supply, distribution data sharing 03/04/21 GC Pharma to support Moderna distribution of 40M doses of COVID-19 Vaccine 02/25/21 Moderna's chief medical officer Tal Zaks to leave company in late September 02/24/21 Moderna makes new capital investment to boost manufacturing capacity TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/26/21 Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham MRNA MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 03/16/21 31st Annual Healthcare Virtual Conference MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish
Recommendations	Costco price target lowered to $395 from $410 at Baird » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 COST Costco $319.35 / -4.53 (-1.40%) Baird analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Costco reports January SSS rose 15.9% 01/06/21 Costco December SSS, ex impact from gas, FX rose 10.9% 01/06/21 Costco December E-commerce sales ex gas, FX up 61.6% 11/24/20 Tinley Beverage Company completes full production at Long Beach facility COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Baird Costco January core comps re-accelerated, says Baird 02/02/21 Cleveland Research Costco U.S. sales slightly improved in January, says Cleveland Research 01/07/21 Deutsche Bank Costco price target raised to $347 from $344 at Deutsche Bank 01/06/21 Baird Costco saw some deceleration in December core comp sales, says Baird COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Costco reports Q2 EPS $2,14, consensus $2.44 03/04/21 Notable companies reporting after market close 12/10/20 Costco reports Q1 total company comparable sales up 15.4% 12/10/20 Costco reports Q1 EPS $2.62, consensus $2.05 COST Costco $319.35 / -4.53 (-1.40%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: After-Hours Movers COST Costco $319.35 / -4.53 (-1.40%) 12/10/20 Costco options imply 3.8% move in share price post-earnings 11/17/20 Early notable gainers among liquid option names on November 17th 09/24/20 Costco options imply 6.0% move in share price post-earnings 09/24/20 Unusually active option classes on open September 24th

Hot Stocks	Daqo signs three-year, 52,700 MT polysilicon supply agreement with Shangji » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 DQ Daqo New Energy $85.93 / -8.76 (-9.25%) Daqo New Energy announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events Options DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Daqo New Energy enters three-year polysilicon supply agreement with Zhonghuan 02/02/21 Daqo New Energy provides update on potential IPO in China 01/13/21 Daqo New Energy falls -6.4% 01/04/21 Daqo New Energy rises 16.1% DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Roth Capital Daqo New Energy price target raised to $115 from $105 at Roth Capital 02/08/21 Roth Capital Bill could be 'meaningful positive' for solar stocks, says Roth Capital 01/26/21 Roth Capital Daqo New Energy price target raised to $100 from $40 at Roth Capital 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 03/09/21 Daqo New Energy - DQ DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/25/21 Daqo New Energy call volume above normal and directionally bullish 01/11/21 Daqo New Energy put volume heavy and directionally bearish
Recommendations	Fulgent Genetics price target raised to $140 from $135 at Piper Sandler » 05:06 03/05/21 03/05 05:06 03/05/21 05:06 FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/16/21 Fulgent Genetics, BioIQ partner on COVID-19 testing programs 12/29/20 Fulgent Genetics extends partnership with NTC DOE and Health 12/17/20 PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program 11/18/20 Fulgent Genetics, LANES, LA DHS partner on COVID-19 testing FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/03/21 Piper Sandler Fulgent Genetics price target raised to $135 from $100 at Piper Sandler 02/01/21 Oppenheimer Fulgent Genetics price target raised to $130 from $75 at Oppenheimer 02/01/21 Oppenheimer Invitae downgraded to Perform on valuation at Oppenheimer 01/08/21 Credit Suisse Fulgent Genetics downgraded to Underperform from Neutral at Credit Suisse FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 03/04/21 Fulgent Genetics sees FY21 EPS $12.50, consensus $11.55 03/04/21 Fulgent Genetics reports Q4 EPS $6.20, consensus $4.05 11/23/20 Fulgent Genetics raises 2020 revenue view to at least $300M from $235M 11/09/20 Fulgent Genetics reports Q3 EPS$2.08 , consensus 55c FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 09/09/20 Report says U.S. may need 193M coronavirus tests per month, STAT reports FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 09/22/20 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 31st Annual Healthcare Virtual Conference
Recommendations	Alphatec price target raised to $19 from $17 at Piper Sandler » 05:05 03/05/21 03/05 05:05 03/05/21 05:05 ATEC Alphatec $15.86 / -0.69 (-4.17%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ATEC Alphatec $15.86 / -0.69 (-4.17%) 02/01/21 Alphatec relocates to new headquarters in Carlsbad 12/17/20 Alphatec to acquire EOS imaging for $79.7M in cash, sees accretion ATEC Alphatec $15.86 / -0.69 (-4.17%) 01/29/21 Piper Sandler Alphatec price target raised to $17 from $12 at Piper Sandler 01/12/21 Piper Sandler Piper remains buyer of Alphatec despite Covid pressures 12/21/20 H.C. Wainwright Alphatec price target raised to $16 from $12 at H.C. Wainwright 12/18/20 Lake Street Alphatec price target raised to $20 from $15 at Lake Street ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Alphatec reports Q4 EPS (35c), consensus (21c) 01/12/21 Alphatec sees 2021 revenue approximately $178M, consensus $183.08M 01/12/21 Alphatec sees 2020 revenue $144.8M-$145.1M, consensus $144.13M 01/12/21 Alphatec sees Q4 revenue $43.8M-$44.1M, consensus $43.66M 14 Oct ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers 10/08/20 Fly Intel: Wall Street's top stories for Thursday 03/08/21 Alphatec
Upgrade	Bombardier upgraded to Outperform from Market Perform at BMO Capital » 05:04 03/05/21 03/05 05:04 03/05/21 05:04 BDRBF Bombardier $0.00 / + (+0.00%) BMO Capital analyst Fadi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BDRBF Bombardier $0.00 / + (+0.00%) 03/04/21 Bombardier targets 2025 total revenues about $7.5B 03/04/21 Bombardier expects business jet deliveries to begin gradual recovery in 2021 03/03/21 Bombardier, Aston Martin sign LOI for custom design services on business jets 02/23/21 Bombardier reports suffering 'limited cybersecurity breach' BDRBF Bombardier $0.00 / + (+0.00%) 02/16/21 Cowen Bombardier downgraded to Underperform from Market Perform at Cowen 02/16/21 Scotiabank Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank 02/12/21 National Bank Bombardier price target lowered to C$0.70 from C$0.80 at National Bank 02/12/21 BMO Capital Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital BDRBF Bombardier $0.00 / + (+0.00%) 02/11/21 Bombardier reports Q4 cont ops EPS (1c), consensus 0c 02/11/21 Bombardier sees FY21 adjusted EBITDA greater than $500M BDRBF Bombardier $0.00 / + (+0.00%) 11/13/20 Disney upgrade among today's top calls on Wall Street 05/06/21 Bombardier - BDRBF
Recommendations	Cutera price target raised to $42 from $38 at Piper Sandler » 05:02 03/05/21 03/05 05:02 03/05/21 05:02 CUTR Cutera $26.21 / -8.715 (-24.96%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera not providing formal guidance at this time CUTR Cutera $26.21 / -8.715 (-24.96%) 02/18/21 Piper Sandler Cutera price target raised to $38 from $28 at Piper Sandler 11/05/20 Piper Sandler Cutera price target raised to $28 from $22 at Piper Sandler 09/14/20 Stephens Cutera price target raised to $24 from $18 at Stephens 08/07/20 Piper Sandler Cutera should be bought at these 'depressed levels,' says Piper Sandler CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera reports Q4 EPS 12c, consensus 4c 11/04/20 Cutera reports Q3 EPS (13c), consensus (33c) 17 Apr CUTR Cutera $26.21 / -8.715 (-24.96%) 11/04/20 Fly Intel: After-Hours Movers 03/18/21 Cutera

Events

Earnings calls, analyst events, roadshows and more

CLLS
Today at 08:00

Cellectis - CLLS Conference Calls
EGLE
Today at 08:00

Eagle Bulk Shipping - EGLE Conference Calls
GSX
Today at 08:00

GSX Techedu - GSX Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
COE
Today at 08:00

China Online Education - COE Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
Today at 08:00

European Capital Goods Industry Meetings
Today at 08:30

Employment Situation--Average Hourly Earnings M/M: February 2021 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Average Hourly Earnings Y/Y: February 2021 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair $44.00-46.25 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Bayer price target lowered to EUR 83 from EUR 86 at Morgan Stanley

TODAY'S FREE FLY STORIES

Get Full Fly Access